Authors
Loading...
Preclinical study demonstrates that NR4A1 drives endothelial cell death via CaMKII-Parkin mitophagy in high-fat models, highlighting a potential therapeutic target for atherosclerosis.
Li et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: